<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Horii Y</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>30765</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371019</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>IL-18 is a unique cytokine that exerts both pro- and anti-inflammatory effects depending on the surrounding environments. Excessive inflammation in the feto-maternal interface is thought to result in the onset of miscarriage and preterm birth, but much is unknown about the function of IL-18 in pregnancy. Here, we report the protective role of IL-18 in pregnancy using lipopolysaccharide (LPS)-induced murine miscarriage models. Whereas a low dose (1 µg) of LPS injection in pregnant mice did not induce miscarriages, the additional injection of anti-IL-18 neutralizing antibody (IL-18 nAb) resulted in a significant increase in abortion rates among the pregnant mice. Under these conditions, multiple T-cell subsets and natural killer cells produced significantly lower levels of the type 1 cytokine IFN-γ and the type 2 cytokine IL-4. The miscarriage induced by the low-dose LPS along with the IL-18 nAb was improved by the supplementation of IFN-γ and IL-4. Furthermore, the main source of IL-18 production was found to be the myometrium rather than macrophages. These results indicated that IL-18, which was initially thought to have a harmful effect on the maintenance of pregnancy, has a protective role in miscarriage against minor stimulation by pathogens with modulating immune homeostasis.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation.</pubmed_title><pmcid>PMC12371019</pmcid><funding_grant_id>20K09679</funding_grant_id><funding_grant_id>22K11505</funding_grant_id><funding_grant_id>16H05178</funding_grant_id><pubmed_authors>Negishi Y</pubmed_authors><pubmed_authors>Suzuki S</pubmed_authors><pubmed_authors>Koike E</pubmed_authors><pubmed_authors>Sasaki F</pubmed_authors><pubmed_authors>Horii Y</pubmed_authors><pubmed_authors>Flavell RA</pubmed_authors><pubmed_authors>Ino H</pubmed_authors><pubmed_authors>Kawamoto Y</pubmed_authors><pubmed_authors>Ishibashi M</pubmed_authors><pubmed_authors>Morita R</pubmed_authors><pubmed_authors>Ohashi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation.</name><description>IL-18 is a unique cytokine that exerts both pro- and anti-inflammatory effects depending on the surrounding environments. Excessive inflammation in the feto-maternal interface is thought to result in the onset of miscarriage and preterm birth, but much is unknown about the function of IL-18 in pregnancy. Here, we report the protective role of IL-18 in pregnancy using lipopolysaccharide (LPS)-induced murine miscarriage models. Whereas a low dose (1 µg) of LPS injection in pregnant mice did not induce miscarriages, the additional injection of anti-IL-18 neutralizing antibody (IL-18 nAb) resulted in a significant increase in abortion rates among the pregnant mice. Under these conditions, multiple T-cell subsets and natural killer cells produced significantly lower levels of the type 1 cytokine IFN-γ and the type 2 cytokine IL-4. The miscarriage induced by the low-dose LPS along with the IL-18 nAb was improved by the supplementation of IFN-γ and IL-4. Furthermore, the main source of IL-18 production was found to be the myometrium rather than macrophages. These results indicated that IL-18, which was initially thought to have a harmful effect on the maintenance of pregnancy, has a protective role in miscarriage against minor stimulation by pathogens with modulating immune homeostasis.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-09T10:46:50.249Z</modification><creation>2026-04-08T00:48:57.618Z</creation></dates><accession>S-EPMC12371019</accession><cross_references><pubmed>40841464</pubmed><doi>10.1038/s41598-025-16546-9</doi></cross_references></HashMap>